Condition: Lymphoma · Refractory B-Cell Lymphoma · Lymphoma, B-Cell · Sponsor: Memorial Sloan Kettering Cancer Center
This study is being done to find out how older patients respond to CAR-T cell therapy and how the treatment affects their quality of life. This is a quality of life study and participating in the study does not involve receiving any treatment, other than the standard treatment for participants' disease.
This description comes directly from the study's public registry record.
Richard Lin, MD, PhD · 646-608-2646 · ABMTTrials@mskcc.org
Sergio Giralt, MD · ABMTTrials@mskcc.org
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04300998